Product
TSC-204
1 clinical trial
20 indications
Indication
Head and Neck CancerIndication
Cervical CancerIndication
Non-small Cell CarcinomaIndication
MelanomaIndication
Ovarian CancerIndication
Anogenital CancersIndication
Human Papillomavirus-Related CarcinomaIndication
HPV-Related Squamous Cell CarcinomaIndication
HPV-related malignancyIndication
HPV-Related AdenocarcinomaIndication
HPV-Related Adenosquamous CarcinomaIndication
Vaginal AdenocarcinomaIndication
HPV-Related Endocervical AdenocarcinomaIndication
Anal Squamous Cell CarcinomaIndication
Penile squamous cell carcinomaIndication
Vulvar Squamous Cell CarcinomaIndication
Rectal Squamous Cell CarcinomaClinical trial
A Phase 1 Basket Study Evaluating the Safety and Feasibility of T-Plex, Autologous Customized T Cell Receptor-Engineered T Cells Targeting Multiple Peptide/HLA Antigens in Participants With Antigen-positive Locally Advanced (Unresectable) or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2026-12-30